Induction of heme oxygenase-1 and stimulation of cGMP production by hemin in aortic tissues from hypertensive rats

Blood

Volumn 101, Issue 10, 2003, Pages 3893-3900

  Ndisang, Joseph Fomusi ^b   Wu, Lingyun ^b   Zhao, Weimin ^b   Wang, Rui ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; CYCLIC GMP; GUANYLATE CYCLASE; HEME OXYGENASE 1; HEMIN; PROTOPORPHYRIN; ZINC; HEME OXYGENASE; HEME OXYGENASE 2; HEME OXYGENASE-2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME DEFICIENCY; HYPERTENSION; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; RAT STRAIN; SOLUBILITY; STATISTICAL SIGNIFICANCE; TISSUE; VASCULAR TISSUE; AGING; ANIMAL; BIOSYNTHESIS; BLOOD PRESSURE; COMPARATIVE STUDY; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; GENETICS; METABOLISM; PATHOPHYSIOLOGY; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE; WISTAR KYOTO RAT;

AGING; ANIMALS; AORTA; BLOOD PRESSURE; CYCLIC GMP; ENZYME INDUCTION; GUANYLATE CYCLASE; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HEMIN; HYPERTENSION; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 0038264420     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-08-2608     Document Type: Article

References (53)

1. Oparil S. Are there meaningful differences in blood pressure control with current anti-hypertensive agents? Am J Hypertens. 2002;15:14S-21S.
2. Sacerdoti D, Escalante B, Abraham NG, McGiff JC, Levere RD, Schwartzman ML. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science. 1989; 243:388-390.
3. Roman RJ, Maier KG, Sun CW, Harder DR, Alonso-Galicia M. Renal and cardiovascular actions of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids. Clin Exp Pharmacol Physiol. 2000;27:855-865.
4. 2S be the third endogenous gaseous transmitter? FASEB J. 2002;16;1792-1798.
5. Wang R. Resurgence of carbon monoxide: an endogenous gaseous vasorelaxing factor. Can J Physiol Pharmacol. 1998;76:1-15.
6. Christova T, Diankova Z, Setchenska M. Heme oxygenase-carbon monoxide signalling pathway as a physiological regulator of vascular, smooth muscle cells. Acta Physiol Pharmacol Bulg. 2000; 25:9-17.
7. Schipper HM. Heme oxygenase-1: role in brain aging and neuro-degeneration. Exp Gerontol. 2000;35:821-830.
8. Morita T, Kourembanas S. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest. 1995;96:2676-2682.
9. Christodoulides N, Durante W, Kroll MH, Schafer AI. Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation. 1995;91:2306-2309.
10. Furchgott RF, Jothianandan D. Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels, 1991; 28:52-61.
11. McCoubrey WK, Huang TJ, Maines MD. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem. 1997;247:725-732.
12. Keyse SM, Tyrrell RM. Heme oxygenase is the major 32-kDa-stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci U S A. 1989;86:99-103.
13. Maines MD, Trakshel GM. Differential regulation of heme oxygenase isozymes by Sn- and Zn-protoporphyrins: possible relevance to suppression of hyperbilirubinemia. Biochim Biophys Acta. 1992;1131;166-174.
14. Yet SF, Pellacani A, Patterson C, et al. Induction of heme oxygenase-1 expression in vascular smooth muscle cells: a link to endotoxic shock. J Biol Chem. 1997;272:4295-4301.
15. Ishikawa K, Sugawara D, Goto J, et al. Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits. Circulation. 2001;104:1831-1836.
16. Horikawa S, Yoneya R, Nagashima Y, Hagiwara K, Ozasa H. Prior induction of heme oxygenase-1 with glutathione depletor ameliorates the renal ischemia and reperfusion injury in the rat. FEBS Lett. 2002;510:221-224.
17. Ndisang JF, Wang R, Vannacci A, et al. Haeme oxygenase-1 and cardiac anaphylaxis. Br J Pharmacol. 2001;134:1689-1696.
18. Sabaawy HE, Zhang F, Nguyen X, et al. Human heme oxygenase-1 gene transfer lowers blood pressure and promotes growth in spontaneously hypertensive rats. Hypertension. 2001;38:210-215.
19. Baum M, Schiff E, Kreiser D, et al. End-tidal carbon monoxide measurements in women with pregnancy-induced hypertension and preeclampsia. Am J Obstet Gynecol. 2000;183:900-903.
20. Kawashima A, Oda Y, Yachie A, Koizumi S, Nakanishi I. Heme oxygenase-1 deficiency; the first autopsy case. Hum Pathol. 2002;33:125-130.
21. Togane Y, Morita T, Suematsu M, Ishimura Y, Yamazaki JI, Katayama S. Protective roles of endogenous carbon monoxide in neointimal development elicited by arterial injury. Am J Physiol Heart Circ Physiol. 2000;278:H623-H632.
22. Ishida Y, Nakamoto H, Imai H, Suzuki S, Okano H, Suzuki H. Heme oxygenase-1 regulates vascular tone of the peritoneum undergoing peritoneal dialysis. Adv Perit Dial. 2001;17:15-19.
23. Wang LJ, Lee TS, Lee FY, Pai RC, Chau LY. Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol. 1998;152:711-720.
24. Cook MN, Nakatsu K, Marks GS, et al. Heme oxygenase activity in the adult rat aorta and liver as measured by carbon monoxide formation. Can J Physiol Pharmacol. 1995;73:515-518.
25. Silva CL, Noel F, Barreiro EJ. Cyclic GMP-dependent vasodilatory properties of LASSBio 294 in rat aorta. Br J Pharmacol. 2002;135:293-298.
26. Ruetten H, Zabel U, Linz W, Schmidt HH. Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats. Circ Res. 1999;85:534-541.
27. Levere RD, Martasek P, Escalante B, Schwartzman ML, Abraham NG. Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. J Clin Invest. 1990;86: 213-219.
28. Martasek P, Schwartzman ML, Goodman AI, Solangi KB, Levere R, Abraham NG. Hemin and L-arginine regulation of blood pressure in spontaneously hypertensive rats. J Am Soc Nephrol. 1991; 2:1078-1084.
29. Ndisang JF, Zhao W, Wang R. Selective regulation of blood pressure by heme oxygenase-1 in hypertension. Hypertension. 2002;40:315-321.
30. Bradford M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-253.
31. Kushida T, Quan S, Yang L, Ikehara S, Kappas A, Abraham NG. A significant role for the heme oxygenase-1 gene in endothelial cell cycle progression. Biochem Biophys Res Commun. 2002;291: 68-75.
32. Thorne GD, Shimizu S, Paul RJ. Hypoxic vasodilation in porcine coronary artery is preferentially inhibited by organ culture. Am J Physiol Cell Physiol. 2001;281:C24-C32.
33. Ndisang JF, Gai P, Berni L, et al. Modulation of the immunological response of guinea pig mast cells by carbon monoxide. Immunopharmacology. 1999;43:65-73.
34. Matsuyama H, Unno T, El-Mahmoudy AM, et al. Peptidergic and nitrergic inhibitory neurotransmissions in the hamster jejunum: regulation of vasoactive intestinal peptide release by nitric oxide. Neuroscience. 2002;110:779-788.
35. Wang R, Wang ZZ, Wu L. Carbon monoxide-induced vasorelaxation and the underlying mechanisms. Br J Pharmacol. 1997;121:927-934.
36. + channels in dorsal vagal neurons of juvenile mice in situ. Neuroscience. 2002;109:313-328.
37. Steiner AL, Parker CW, Kipnis DM. Radioimmunoassay for cyclic nucleotides: preparation of antibodies and iodinated cyclic nucleotides. J Biol Chem. 1972;247:1106-1113.
38. 2S-induced vasorelaxation and the underlying cellular and molecular mechanisms. Am J Physiol. 2002;283:H474-H480.
39. Mulsch A, Bauersachs J, Schafer A, Stasch JP, Kast R, Busse R. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br J Pharmacol. 1997; 120:681-689.
40. Kojda G, Kottenberg K, Hacker A, Noack E. Alterations of the vascular and the myocardial guanylate cyclase/CGMP-system induced by long-term hypertension in rats. Pharm Acta Helvv. 1998;73: 27-35.
41. Papapetropoulos A, Marczin N, Mora G, Milici A, Murad F, Catravas JD. Regulation of vascular smooth muscle soluble guanylate cyclase activity, MRNA, and protein levels by CAMP-elevating agents. Hypertension. 1995;26:696-704.
42. Kloss S, Bouloumie A, Mulsch A. Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase. Hypertension. 2000;35:43-47.
43. Lou D, Vincent SR. Metalloporphyrins inhibit nitric oxide-dependent CGMP formation in vivo. Eur J Pharmacol. 1994;267:263-267.
44. Grundemar L, Ny L. Pitfalls using metalloporphyrins in carbon monoxide research. Trends Pharmacol Sci. 1997;18:193-195.
45. Zakhary R, Gaine SP, Dinerman JL, Ruat M, Flavahan NA, Snyder SH. Heme oxygenase 2: endothelial and neuronal localization and role in endothelium-dependent relaxation. Proc Natl Acad Sci U S A. 1996;93:795-798.
46. Motterlini R, Gonzales A, Foresti R, Clark JE, Green CJ, Winslow RM. Heme oxygenase-1 derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Clrc Res. 1998;83:568-577.
47. Appleton SD, Chretien ML, McLaughlin BE, et al. Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations. Drug Metab Dispos. 1999;27:1214-1219.
48. Johnson RA, Lavesa M, DeSeyn K, Scholer MJ, Nasjletti A. Heme oxygenase substrates acutely lower blood pressure in hypertensive rats. Am J Physiol. 1996;271:H1132-H1138.
49. Motterlini R, Foresti R, Bassi R, Calabrese V, Clark JE, Green CJ. Endothelial heme oxygenase-1 induction by hypoxia: modulation by inducible nitric-oxide synthase and S-nitrosothiols. J Biol Chem. 2000;275:13613-13620.
50. Lin H, McGrath JJ. Vasodilating effects of carbon monoxide. Drug Chem Toxicol. 1988;11:371-385.
51. McFaul SJ, McGrath JJ. Studies on the mechanism of carbon monoxide-induced vasodilation in the isolated perfused rat heart. Toxicol Appl Pharmacol. 1987;87:464-473.
52. Chiu H, Brittingham JA, Laskin DL. Differential induction of heme oxygenase-1 in macrophages and hepatocytes during acetaminophen-induced hepatotoxicity in the rat: effects of hemin and biliverdin. Toxicol Appl Pharmacol. 2002;181:106-115.
53. O'Rourke MF, Staessen JA, Vlachopoulos C, Duprez D, Plante GE. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens. 2002;15:426-444.